Ginkgo biloba 1x

Ginkgo is a recognized medicine for insufficient cerebral circulation, peripheral vascular problems and for neuro-sensorial affections of circulatory origin relating to ears, nose, throat and eyes.  It is a proved homoeopathic medicine. The pathogenesis covers weakness of memory and difficulty to think, trembling, insomnia, difficult deglutition, ocular balls painful, heaviness in frontal region and vertigo, buzzing sensation of blockage of ears with diminution of auditive acuity, general lameness with chill, headache (cannot keep head straight without support); all symptoms are better by heat.1

The pharmacology of Ginkgo biloba exhibited Prolyl endopeptidase (PEP) inhibition, suggestive of its role in learning and memory process, major depressions, and senile dementia.  Studies have revealed that PEP activities are significantly higher in Alzheimer’s patients.2 Other studies suggest improvement of cerebral circulation aiding memory, helping cases of dementia; its anti-inflammatory action is deep down to auto-immune problems including multiple sclerosis; it inhibits platelet activating factor (PAF).3  PAF causes blood to become stickier and, therefore, more likely to produce blood clots, induces various inflammations and allergic changes. Research on the drug is continuing but the core action is improving cerebral circulation. 

Where to remember Schwabe’s Ginkgo biloba 1X tablets?

• Insufficient cerebral circulation and the symptoms arising thereof.
• Buzzing in the ears (Tinnitus).
• Vertigo & incoordinated movement.
• Trembling of hands.

It can be used alone or as supplement to other medicines.

Dosage:  Unless otherwise prescribed by the physician, 1-2 tablets 2-3 times daily.  In acute conditions two tablets every hour for a day. If complaints are not relieved, consult a specialist.

Side effects:  No side effects of Ginkgo biloba 1X are known.  

Contraindications:  No contraindications for the use of Ginkgo biloba 1X are known.

Interactions:  No interactions between Ginkgo biloba 1X and other products are known.

Presentation:  Bottle of 20g.

References

1. O. A. Julian, Materia Medica of New Homoeopathic Remedies, RadarOpus 1.33 (Homoeopathic Software), Archibel S.A. Rue Fontaine St. Pierre 1E, Zoning Industriel de la Fagne, 5330 Assesse, Belgium.
2. Lee JH et al. Prolyl endopeptidase inhibitors from the leaves of Ginkgo biloba. Plant Medica, Vol. 70, Dec. 2004.
3. Andrew Chevallier, The Encyclopedia of Medicinal Plants, 1st Edition, 1996, Dorling Kindersley, London.